As of April 1, 2026, SELLAS Life Sciences Group Inc. (SLS) trades at a current price of $4.28, marking a 1.06% gain in the most recent trading session. The clinical-stage biotech firm, which focuses on developing novel targeted cancer immunotherapies, has seen relatively range-bound price action in recent weeks, with market participants closely monitoring key technical levels for signals of potential near-term momentum shifts. No recent earnings data is available for SLS at the time of writing,
SLS Stock Analysis: SELLAS Life Sciences Group Inc. gains 1.06 pct, trades at 4.28 level
SLS - Stock Analysis
3374 Comments
1125 Likes
1
Rhiatt
Senior Contributor
2 hours ago
{协议答案}
👍 292
Reply
2
Lynnzee
Community Member
5 hours ago
{协议答案}
👍 45
Reply
3
Audy
Daily Reader
1 day ago
{协议答案}
👍 165
Reply
4
Ivonn
Loyal User
1 day ago
{协议答案}
👍 84
Reply
5
Secundina
Expert Member
2 days ago
{协议答案}
👍 245
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.